With the rapid development of biomedicine, nanotechnology, and precision medicine, the design of medical devices and biomedical materials is moving towards nanoscale, high complexity, and high functionality. From viruses and vaccines, nanodrug carriers, liposomes to various biomedical nanomaterials, their microstructure, particle size distribution, and material composition often directly affect product performance and safety. Therefore, in the research and development and quality control processes of biomedical products, in-depth analysis of their structure and physicochemical properties through high-resolution material analysis and imaging technology has become an indispensable important aspect.

 

MA-tek integrates biomedical sample preparation technology and high-resolution electron microscopy analysis capabilities to provide material structure analysis and nanoscale imaging observation services for biomedical and medical devices. Through various professional sample preparation methods such as negative staining, cryo-samples, ultrathin sections, and liquid sample observation, microstructure observation and component analysis of viruses, vaccines, nanodrugs, and various biomedical materials can be conducted while maintaining the original structure of the samples. These analytical techniques can assist researchers in gaining a deeper understanding of the nanoscale morphology, particle size, and material distribution of biological samples, providing key data for the development and quality verification of biomedical materials.

 

In the field of nanomaterial analysis, MA-tek has also developed the patented K-kit liquid sample electron microscopy technology, which can maintain samples in their original liquid state in the high vacuum environment of the electron microscope, allowing for the observation and analysis of nanoparticles, aggregates, and agglomerated structures under conditions close to the actual environment. Through this technology, the types, shapes, particle size distribution, particle concentration, and aggregation and agglomeration states of nanoparticles can be accurately assessed, providing quantitative analysis results of nanomaterials that meet regulatory requirements.

 

Through interdisciplinary material analysis and biomedical sample observation capabilities, MA-tek can assist the medical device and biomedical industry in providing professional testing and analysis services at stages such as product development, material identification, nanodrug development, and quality verification, enhancing product safety and reliability, and accelerating the innovative development of the next generation of biomedical technologies.